DZDaria Ziemińska

Daria Ziemińska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daria Ziemińska has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Rafał Burczyk

    Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland

    7 shared publications
  • Martyna Michalska

    Department and Clinic of Geriatrics, and Internal Medicine Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland

    5 shared publications
  • Cezary Guzowski

    Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland

    4 shared publications
  • Elżbieta Tokarczyk

    Szpital Św. Wincentego a Paulo w Gdyni, ul. Wójta Radtkego 1, 81-348 Gdynia

    4 shared publications
  • Joanna Murawska

    Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland

    4 shared publications
  • Karolina Winiarek

    Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland

    4 shared publications

Latest Publications

  • Open Access

    Automated Recognition of Abnormalities in Gastrointestinal Endoscopic Images – Evaluation of an AI Tool for Identifying Polyps and Other Irregularities

    by Weronika Jarych, Elżbieta Tokarczyk, Patryk Iglewski, Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Michał Kociński, Jan Reinald Wendt

    This study investigates the application of artificial intelligence (AI) for the automatic detection of pathological abnormalities in gastrointestinal endoscopic images. Specifically, it evaluates the performance of an AI tool in identifying and classifying lesions such as polyps and other irregularities, including inflammatory changes, within real-time endoscopic procedures. The primary objective is to assess the tool's diagnostic accuracy and its potential to improve lesion detection, thereby reducing the likelihood of overlooked abnormalities. Leveraging advanced machine learning techniques, particularly convolutional neural networks (CNNs), the AI system aims to enhance diagnostic precision and support clinicians in making prompt, evidence-based decisions. Key advantages of AI integration in endoscopy include improved sensitivity, minimized detection errors, and the potential to optimize clinical workflow efficiency. However, the study also addresses significant challenges, including the necessity for large, heterogeneous datasets for model validation, the need for standardized AI applications, and the ethical implications of AI-assisted clinical decision-making. Additionally, the potential benefits of combining AI with complementary imaging technologies, such as fluorescence imaging and spectroscopy, are explored to further enhance diagnostic capabilities. In conclusion, the study highlights the promising role of AI in gastrointestinal endoscopy while underscoring the importance of continued research, algorithmic refinement, and the establishment of regulatory frameworks to fully harness its clinical potential.

  • Open Access

    The role of Artificial Intelligence in detecting breast lesions using ultrasound

    by Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Elżbieta Tokarczyk, Martyna Michalska, Adam Łabuda

    Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.

  • Open Access

    Advancements in Corneal Transplantation: Addressing Rejection Risks, Innovations and Challenges

    by Daria Ziemińska, Karina Motolko, Rafał Burczyk, Konrad Duszyński, Elżbieta Tokarczyk

    Introduction and Objective: Corneal transplantation is an increasingly common surgical procedure, with lamellar keratoplasty now favored over penetrating keratoplasty due to its advantages in outcomes and precision. Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "corneal transplantation rejection" and "high risk of rejection," underscores the need for advancements in understanding and managing graft rejection. Brief knowledge status: Key insights highlight the importance of deeper exploration into the immunological mechanisms of rejection to refine therapeutic strategies. The development of bioengineered materials like acellular porcine corneal stroma (APCS) offers a promising solution to the global donor shortage, though further validation of their clinical utility is needed. Complementary therapies such as amniotic membrane transplantation show promise in mitigating graft failure and treating corneal surface disorders due to their anti-inflammatory and regenerative properties. Moreover, comparative studies suggest that advanced keratoplasty techniques, such as Descemet Membrane Endothelial Keratoplasty (DMEK), may achieve lower rejection rates compared to alternatives like Descemet Stripping Automated Endothelial Keratoplasty (DSAEK). Discussion: Future priorities include advancing drug delivery systems, ensuring the feasibility and accessibility of bioengineered materials, and conducting large-scale multicenter trials to validate novel treatments and surgical methods across diverse populations. Summary: Addressing these challenges is particularly crucial for high-risk and pediatric patients, with the ultimate goal of reducing graft failure rates and the necessity for repeat interventions.


  • Open Access

    Colostrum: The Golden Elixir of Health – Unveiling Its Multifaceted Benefits in Modern Medicine

    by Martyna Michalska, Karolina Winiarek, Wiktor Wardyn, Elżbieta Tokarczyk, Daria Ziemińska, Cezary Guzowski, Rafał Burczyk, Joanna Murawska

    Introduction: Colostrum is uniquely rich in immunoglobulins, growth factors, antibacterial peptides, probiotics, prebiotics, and essential vitamins and minerals. Available as a supplement, BC is used to prevent gastrointestinal infections, boost immune support, and aid in managing chronic inflammation, autoimmune diseases, and even athletic recovery. Aim: The aim of this article is to assess the potential benefits of colostrum across various health areas, including gastrointestinal health, immune system support, respiratory diseases, dermatology, autoimmune conditions and the development of preterm infants. The article will also present a critical analysis of current scientific data and examine future research directions and therapeutic advancements. Review methods: This article is based on a comprehensive, non-systematic review of the scientific literature. A thorough search of the PubMed database was conducted, and 45 sources published up to 2024 were analyzed to ensure that the information presented is current and relevant. Abbreviated description of the state of knowledge: Analysis of the literature suggests that colostrum may provide passive protection, reduce inflammation and support gut integrity in preterm infants. Inflammatory bowel disease may benefit from colostrum, though results for IBS are mixed. It aids wound healing, has anti-aging effects, and shows potential in autoimmune disease management. It also boosts respiratory immunity and aids athletes' recovery and performance. Conclusions: Colostrum contains bioactive components like immunoglobulins, lactoferrin, and growth factors. While current studies highlight its benefits in enhancing immunity, supporting gut health, and managing inflammatory conditions, more comprehensive clinical trials are required to confirm its efficacy and safety across various populations and health conditions.


  • Open Access

    Impact of Gut Microbiota on the Development of Diseases

    by Karolina Winiarek, Martyna Michalska, Wiktor Wardyn, Cezary Guzowski, Joanna Anna Murawska, Daria Ziemińska, Rafał Burczyk, Kornelia Kędziora-Kornatowska

    Aim: The aim of this article is to review the latest scientific research on the influence of intestinal microbiota on the development of diseases. In this article we will discuss the importance of the intestinal microbiota, the differences in the composition of the microbiota between healthy and sick people and the relationship between the intestinal microbiota and metabolic, inflammatory, cardiovascular and neurodegenerative diseases. Abbreviated description of the state of knowledge: The gut microbiota plays a key role in human health by influencing the development and progression of various diseases. Numerous studies have shown that an imbalance in gut microbiota, called dysbiosis, may be linked to a number of conditions. Intestinal microflora interacts with the immune system, modulates inflammation and influences metabolic pathways, which emphasizes its importance in the development of diseases. Conclusions: Intestinal microflora is crucial to health, regulating immune, metabolic and neurological functions. Dysbiosis, i.e. disturbance of the balance of intestinal microflora, is associated with diseases such as type 2 diabetes, obesity, inflammatory bowel diseases, allergies, autoimmune diseases and neuropsychiatric disorders. Healthy microflora, influenced by diet, pH and nutrients, are essential for metabolism, immune system regulation and neuronal communication. Recently, scientists have become interested in the possibility of using this knowledge in treatment. Appropriate dietary management, probiotic supplementation and fecal microflora transplantation show promising potential. Future research should focus on elucidating the specific mechanisms by which the gut microbiota influences disease processes and developing targeted therapies to exploit the therapeutic potential of the microbiota.


  • Open Access

    Cutting-Edge Approaches in Urinary Incontinence Treatment: A Comprehensive Review

    by Karolina Winiarek, Martyna Michalska, Wiktor Wardyn, Cezary Guzowski, Joanna Murawska, Daria Ziemińska, Rafał Burczyk, Kornelia Kędziora-Kornatowska

    Introduction: Urinary incontinence is a prevalent health issue that profoundly impacts the quality of life for patients worldwide. Traditional treatments, including pharmacotherapy and surgical procedures, often fall short, leaving many individuals struggling with bladder control issues that restrict physical and social activities and cause significant psychological distress. Recent advancements in therapeutic methods—encompassing behavioral therapies, cutting-edge medical technologies, innovative pharmacotherapy, and advanced surgical techniques—offer promising alternatives. By exploring the effectiveness and advantages of these novel approaches, we can enhance treatment accessibility and elevate the quality of care for those affected by urinary incontinence, ultimately improving their daily functioning and overall well-being. Abbreviated description of the state of knowledge:Current research on innovative treatments for urinary incontinence indicates significant advancements in enhancing patients' quality of life. These cutting-edge methods encompass behavioral therapies like pelvic floor muscle training, state-of-the-art medical technologies such as nerve stimulation, new pharmacological treatments with high efficacy and minimal side effects, and advanced surgical interventions, including artificial sphincter implants and urinary tract modifications. Conclusions: Urinary incontinence is a prevalent health issue that significantly deteriorates the quality of life, particularly affecting half of women and one-third of men over the age of 80. As our society ages and the number of individuals affected by this condition rises, understanding and advancing treatment methods become increasingly crucial. Ongoing research aims to discover new and improved therapeutic approaches with minimal side effects, offering hope for enhanced patient outcomes and better management of urinary incontinence in the future.


  • Open Access

    Exploring Haptoglobin as a Promising Marker for Severe Liver Diseases: A Comprehensive Review

    by Daria Ziemińska, Rafał Burczyk, Wiktor Wardyn, Martyna Michalska, Karolina Winiarek, Joanna Murawska, Cezary Guzowski, Kornelia Kędziora-Kornatowska

    Liver damage is a common symptom of many diseases, including metabolic disorders and cancers. Such patient condition requires effective examinations aimed at prompt diagnosis and implementation of the most appropriate treatment for a specific disease. Haptoglobin, the subject of many studies, has proven to be a protein that can be used as a biomarker of liver damage, thereby aiding not only in the diagnosis but also in the treatment, resulting in more favorable prognoses regarding patient longevity and quality of life.The aim of this study is to elucidate the role of haptoglobin as a diagnostic and prognostic biomarker in cases of liver damage.This is a review of scientific literature and analysis of clinical data regarding haptoglobin levels in liver damage were conducted to assess the reliability of haptoglobin as a biomarker.This paper primarily utilized the latest publications produced after 2015. PubMed and Google Scholar were used to find relevant publications. All cited works provided useful information to achieve the aim of our article.Analysis of the literature suggests that haptoglobin levels may be significantly associated with the development and severity of liver damage. It may serve as a suitable biomarker for diagnosing diseases that coincide with hepatocyte damage, thus improving the diagnosis of these diseases and increasing the chance of appropriate treatment, which may contribute to prolonging and improving the patient's quality of life.Haptoglobin appears to be a promising biomarker in liver damage; however, further research is necessary to confirm its diagnostic and prognostic accuracy. Haptoglobin exists in various genotypic forms, each characteristic of different disease entities. Understanding the mechanisms regulating haptoglobin levels may lead to a better understanding of liver damage pathogenesis and the development of more effective therapies, increasing the chance of patient recovery and improving their quality of life.